Last reviewed · How we verify
NCT02564991
Study of Structural Imaging
trial in Chemically-Induced Disorders in 98 participants. Completed in 18 March 2020.
18 March 2020
Quick facts
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 98 |
| Start date | 29 February 2016 |
| Primary completion | 18 March 2020 |
| Estimated completion | 18 March 2020 |
| Sites | 1 location across United States |
Conditions studied
- Chemically-Induced Disorders — all drugs for Chemically-Induced Disorders →
- Substance-Related Disorders — all drugs for Substance-Related Disorders →
- Mental Disorders — all drugs for Mental Disorders →
- Alcohol Dependence — all drugs for Alcohol Dependence →
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Who can join
Adults 30 to 60, any sex, with Chemically-Induced Disorders or Substance-Related Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The way alcohol affects brain structure has been widely studied. But the way it affects all parts of the brain is still unknown. Researchers want to use magnetic resonance imaging (MRI) scans to study brain structure and function. They hope this will help them better understand changes that happen in brain regions during treatment of alcohol use disorders. Objectives: To study changes in the brain by using MRI in people with and without alcohol use disorders. To study how brain changes affect gait, balance, cognitive ability, and behavior. To see how the brain recovers when alcohol use stops. Eligibility: People with alcohol dependence who are currently hospitalized in a particular unit at NIH. Healthy volunteers 30 60 years old without an alcohol use disorder. Design: Participants will be screened under a separate protocol. Participants will give a urine sample for a drug test and pregnancy test at each study visit. They will also have to pass a breath alcohol test. At the first visit, participants will have an MRI. The scanner is a metal cylinder in a strong magnetic field. Participants will lie on a table that slides in and out of the cylinder. They will do behavior and memory tasks outside the scanner. They will have gait and balance tested. They will have to stand on both legs, stand on just one leg, and walk in a straight line. They will perform each task with eyes open, then with eyes closed. They will have tests of memory, thinking, and problem solving. Some participants will have a second visit. They will have another MRI and repeat some of the behavior and memory tasks. ...
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02564991
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chemically-Induced Disorders
Currently open trials in the same condition.
- NCT06810076 — Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care · NA · active not recruiting
- NCT06387290 — Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits · Phase 3 · recruiting
Other National Institute on Alcohol Abuse and Alcoholism (NIAAA) trials
Trials by the same sponsor.
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
- NCT06819189 — Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors · Phase 1 · recruiting
- NCT06269627 — Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder · Phase 4 · recruiting
- NCT06484075 — Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02564991 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Last refreshed: 6 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02564991.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing